Invea Therapeutics, Inc. (INAI)

Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 6, 2026.

IPO Price Range

$10.00 - $12.00

Shares Offered

3,200,000

Deal Size

$35.20M

Invea Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-7.1	-5.7	-3.62
Net Income	-8.05	-5.75	-3.62

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.6	0.59	0.32
Total Debt	3.26	1.82	1.16
Net Cash (Debt)	-2.66	-1.23	-0.84
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-5.26	-5.25	-3.09
Capital Expenditures	-0.01	-0.01	-0.01
Free Cash Flow	-5.27	-5.26	-3.1
Free Cash Flow Growth	-	-	-